International Society for Extracellular Vesicles Revenue and Competitors

Mount Royal, USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • International Society for Extracellular Vesicles's estimated annual revenue is currently $1.1M per year.(i)
  • International Society for Extracellular Vesicles's estimated revenue per employee is $135,000

Employee Data

  • International Society for Extracellular Vesicles has 8 Employees.(i)

International Society for Extracellular Vesicles's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$750M192-1%N/AN/A
Add Company

What Is International Society for Extracellular Vesicles?

keywords:N/A

N/A

Total Funding

8

Number of Employees

$1.1M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

International Society for Extracellular Vesicles News

2022-04-20 - INOVIQ : IIQ Appendix 4C & Quarterly Activities Report - March 2022

7 International Society for Extracellular Vesicles, Lyon, France 25-29th May, 2022. 2.4 OTHER RESEARCH. INOVIQ provided notice to end its...

2022-04-17 - Asteltoxin inhibits extracellular vesicle production through ...

Therefore, in this article, following the recommendations of the International Society for Extracellular Vesicles, we continue to use the...

2022-04-13 - Application of Extracellular Vesicles mediated miRNAs in OA ...

To address the confusion of naming, the International Society for Extracellular Vesicles (ISEV) suggested: “extracellular vesicles” (EVs) as the...

2021-04-20 - International Society for Extracellular Vesicles Launches EV Club

The International Society for Extracellular Vesicles While the EV Club does not replace our Annual Event, it does offer another opportunity for information sharing and connection among members of the EV community. - Joe Sapp, MBA, CAE, ISEV Executive Director MOUNT ROYAL, N.J. (PRWEB) April 20, ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.2M22-12%N/A
#2
N/A3815%N/A
#3
$7.7M393%N/A
#4
$8.4M438%N/A
#5
$16.6M1199%N/A